Continuous Glucose Monitoring as an Additional Tool in Early Cystic Fibrosis-Related Diabetes Monitoring and in Evaluation of Short-Term Sitagliptin Response
Cystic fibrosis-related diabetes (CFRD) is a complication associated with a negative prognosis in patients with cystic fibrosis (CF). Although the oral glucose tolerance test (OGTT) is the widely recommended screening test for CFRD diagnosis, continuous glucose monitoring (CGM) is increasingly consi...
Main Authors: | Fernando Sebastian-Valles, José Alfonso Arranz Martín, Rosa María Girón, Carolina Knott-Torcal, Miguel Antonio Sampedro-Nuñez, Jose Carlos Martin-Adan, Jessica Jiménez-Díaz, Mónica Marazuela |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-06-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/11/6/1754 |
Similar Items
-
The role of modulators in cystic fibrosis related diabetes
by: Lina Merjaneh, et al.
Published: (2022-03-01) -
Rapid-Acting Insulin Used to Treat a Case of Early Cystic Fibrosis–Related Diabetes Complicated by Post Prandial Hypoglycemia
by: Tamar Wolinsky, MD, et al.
Published: (2023-09-01) -
Efficacy of advanced hybrid closed loop systems in cystic fibrosis related diabetes: a pilot study
by: Marta Bassi, et al.
Published: (2024-06-01) -
Sitagliptin: the world’s first DPP-4 inhibitor
by: N. A. Petunina, et al.
Published: (2019-08-01) -
Cystic fibrosis autoantibody signatures associate with Staphylococcus aureus lung infection or cystic fibrosis-related diabetes
by: Ruchi Yadav, et al.
Published: (2023-09-01)